Tag Archives: AstraZeneca

AstraZeneca heart drug fails in key stroke trial

LONDON (Reuters) – AstraZeneca’s heart drug Brilinta has failed to help stroke patients as hoped in a big clinical trial, dealing a blow to the company’s expectations that the medicine could rack up annual sales of $ 3.5 billion by 2023. Reuters: Health News

Read More »